NCT05161533 Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial Status WITHDRAWN Phase PHASE2
NCT05156970 Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC Status COMPLETED Phase PHASE2
NCT05152147 A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05142865 Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas Status UNKNOWN Phase PHASE2
NCT05137262 A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05136677 A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants Status COMPLETED Phase PHASE2
NCT05132985 Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT05125055 Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC Status RECRUITING Phase PHASE2/PHASE3
NCT05118854 A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05116462 Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05105672 A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer Status UNKNOWN Phase PHASE2
NCT05104788 A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT05076942 Groningen International Study on Sentinel Nodes in Vulvar Cancer-III Status RECRUITING Phase PHASE2
NCT05075980 Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05063552 Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05061550 Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT05058651 Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung Status SUSPENDED Phase PHASE2/PHASE3
NCT05050162 Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer Status SUSPENDED Phase PHASE2/PHASE3
NCT05048797 A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05039606 Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma Status NOT_YET_RECRUITING Phase PHASE2